Ask AI
ProCE Banner Activity

Maintenance Therapy in the First-line Setting of HER2+ Metastatic Breast Cancer

Slideset

Download slides from a live webinar to gain expert perspectives on contemporary first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer. 

Released: March 20, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Target Audience

This activity is intended for oncologists, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals who care for patients with breast cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the role of maintenance therapy in the first line treatment setting for patients with HER2+ MBC and its impact on the therapeutic index, toxicity, treatment de-escalation, and the burden of treatment for patients

  • Discuss the role of endocrine therapy in the treatment of patients with HER2+/HR+ MBC in the first line setting

  • Develop and apply individualized treatment plans and multi-drug management strategies in the maintenance setting for patients with MBC

  • Assess and implement the latest clinical evidence regarding advancements made in the standard of care in the first line setting for patients with HER2+ MBC